The Latest Breaking News from Pfizer

The U.S. government is preparing to launch vaccines for children below five in conjunction with educational and outreach efforts, pending approval by federal regulators, the Wall Street Journal reports. The government looks to provide ten million initial doses as the virus spreads nationwide, leaving the parents anxious. The vaccinations could begin…

US stock futures traded mixed this morning on Thursday. Investors, meanwhile, focused on some notable insider trades.

Some people who take Pfizer's oral antiviral for Covid-19 report testing negative after treatment only to test positive again days later.

Pre-orders of vaccines for children under age five have been slow, but Biden administration senior officials say they are not alarmed and expect the pace to pick up after federal approvals later this month.

White House officials say orders have been coming in for COVID-19 vaccine doses for small children

A COVID-19 vaccine that could soon win federal approval may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused the other coronavirus vaccines for religious reasons

Cathie Wood led Ark Invest on Wednesday initiated a position in Moderna Inc (NASDAQ: MRNA) after the biotech company said an updated version of its COVID-19 booster vaccine appeared to provide strong

Australian teenagers aged 12-15 who are at risk of severe disease will be able to receive a COVID-19 booster shot from as early as next week.

Confusion and lack of awareness around who qualifies for COVID antivirals — and who doesn't — may be why some eligible patients aren't getting the medications.

After last week's scare stirred by the release of the Food And Drug Administration's briefing documents, Novavax (NASDAQ: NVAX) can now heave a sigh of relief.

With three COVID-19 vaccines already authorized by the U.S. Food and Drug Administration, Americans have easy access to plenty of shots.